bioRxivSynthetic BiologyPreprint
mBER: Controllable de novo antibody design with million-scale experimental screening
Erik Swanson, Michael Nichols, Supriya RavichandraniD, Pierce Ogden
Abstract
AO_SCPLOWBSTRACTC_SCPLOWRecent machine learning approaches have achieved high success rates in designing protein binders that demonstrate in vitro binding to their targets. While open models for unconstrained "minibinder" design have shown great experimental promise, methods for designing binders in specific formats, such as antibodies, have lagged behind in experimental success rates. In this work, we present mBER, an open-source protein binder design system capable of designing antibody-format binders with state-of-the-art experimental success rates. mBER builds on the ColabDesign framework, achieving successful antibody design primarily through the inclusion of informative sequence and structure conditioning information. Using mBER, we designed two libraries comprising over 1 million VHH binders against 436 diverse targets. We experimentally screened the two libraries against 145 of these targets, resulting in a dataset of over 100 million binding interactions. We achieved specific and significant design success against 45% of targets. In a filtered set of designs, we detect binding rates to specific epitopes as high as 38%. Through mBER, we demonstrate that format-specific binder design is possible with no additional training of underlying folding and language models. This work represents the largest reported de novo protein design and validation campaign, and one of the first open-source methods to demonstrate double-digit percentage experimental success rates for antibody binder design.
- assay: protein sequence
- research focus: protein design
- research focus: drug response / drug discovery
- research focus: benchmarking
- research focus: software / tool
- approach: deep learning
- approach: statistical model
- Citations
- 12
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MIMOSA: Guiding De Novo Antibody Design with Natural Interaction Fingerprints
Brennan Abanades, Andrea Roncoli, … Anna Vangone·bioRxiv·Sep 29, 2026
- PXDesign: Fast, Modular, and Accurate De Novo Design of Protein Binders
Protenix Team, Milong Ren, … Wenzhi Xiao·bioRxiv·Aug 15, 2025
- Efficient generation of epitope-targeted de novo antibodies with Germinal
Luis Santiago Mille, Claudia L. Driscoll, … Xiaojing J. Gao·bioRxiv·Sep 19, 2025
- IgDesign: In vitro validated antibody design against multiple therapeutic antigens using inverse folding
Amir Shanehsazzadeh, Julian Alverio, … Sharrol T. Bachas·bioRxiv·Dec 8, 2023
- Fold-Conditioned De Novo Binder Design via AlphaFold2-Multimer Hallucination.
Khondamir R Rustamov, Artyom Y. Baev·bioRxiv·Jul 2, 2025
- Precise, Specific, and Sensitive De Novo Antibody Design Across Multiple Cases
Yewon Bang, Hyeonjin Cha, … Min Ji Yoon·bioRxiv·Mar 9, 2025